Concepedia
Movement Disorders · 1999 · 13 citations · 6 references
Life SciencesNeurosciencePharmacologyNeurochemistryNeurodegenerationNeuropharmacologyDopaminergic PharmacologyMonoamine NeurochemistryNeurodegenerative Disease PharmacologyParkinson DiseaseParkinsonian Disorders
6
A novel enzyme enantio-selectively synthesizes (R)salsolinol, a precursor of a dopaminergic neurotoxin, N-methyl(R)salsolinol
Makoto Naoi, Wakako Maruyama, P. Dostert et al. · Neuroscience Letters · 1996 · 128 citations
Life Sciences, Neuroscience, Pharmacology +8
A dopaminergic neurotoxin, (<i>R</i>)‐N‐methylsalsolinol, increases in parkinsonian cerebrospinal fluid
Wakako Maruyama, Takashi Abe, Hideo Tohgi et al. · Annals of Neurology · 1996 · 103 citations
Medicine, Neuroscience, Pharmacology +15
(<i>R</i>) salsolinol <i>N</i>‐methyltransferase activity increases in parkinsonian lymphocytes
Makoto Naoi, Wakako Maruyama, Naoki Nakao et al. · Annals of Neurology · 1998 · 66 citations
Life Sciences, Neuroscience, Pharmacology +7
Stereospecific occurrence of a parkinsonism-inducing catechol isoquinoline, n-methyl(R)salsolinol, in the human intraventricular fluid
W. Maruyama, Hirotaro Narabayashi, P. Dostert et al. · Journal of Neural Transmission · 1996 · 42 citations
Life Sciences, Neuroscience, Pharmacology +9
N-methyl-(R)-salsolinol and its relevance to Parkinson's disease
Manfred Gerlach, Eleni Koutsilieri, Peter Riederer · The Lancet · 1998 · 22 citations
Life Sciences, Neuroscience, Pharmacology +10